Furegrelate sodium T11339
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Furegrelate Sodium inhibits human platelet microsomal thromboxane A2 (TxA2) synthase with an IC50 of 15 nM. Furegrelate Sodium is being developed as an antiplatelet agent.Furegrelate Sodium is a potent, orally available, and selective thromboxane synthase
CAS nr:
85666-17-7
Purity:
98%
Molecular Weight:
275,23
SMILES:
O=C(C1=CC2=CC(CC3=CC=CN=C3)=CC=C2O1)O[Na]
Formula:
C15H10NNaO3
Pathway:
Others
Target:
Others
